Feedback / Questions
RhuDex (AV 1142742) - Active Biotech, Dr Falk, Medigene
Medigene: Corporate Presentation
(MediGene)
-
Aug 15, 2013 -
Anticipated initiation of P2 trial for primary biliary cirrhosis in H1 2014
Anticipated new P2 trial
•
Immunology
http://www.medigene.com/sites/default/files/downloads/130812_corppresentation_august2013_0.pdf
Aug 15, 2013
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.